))
ICT Ep13: Q2'24 The quarterly recap with Joel White (Part 3 of 3)
Manage episode 438778255 series 3578161
Content provided by Liam Eves and Ted Trafford, Liam Eves, and Ted Trafford. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Liam Eves and Ted Trafford, Liam Eves, and Ted Trafford or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom.
In today's session we chat with Joel White from Marketcap Consulting about the financial performance of the clinical development space. In the final part of our 3 part discussion we talk through book to bill ratios, find out what is concerning Joel with the market and dive deeper into the Walgreens and BARDA agreement.
15 episodes
Share
